Hikma Pharmaceuticals (Hikma Pharmaceuticals) Beginning Cash Position : $143 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Beginning Cash Position?

Hikma Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2023 was $143 Mil.

Hikma Pharmaceuticals's quarterly Beginning Cash Position declined from Dec. 2022 ($316 Mil) to Jun. 2023 ($270 Mil) and declined from Jun. 2023 ($270 Mil) to Dec. 2023 ($143 Mil).

Hikma Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2021 ($323 Mil) to Dec. 2022 ($371 Mil) but then declined from Dec. 2022 ($371 Mil) to Dec. 2023 ($141 Mil).

Hikma Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Hikma Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Beginning Cash Position Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

276.00

442.00

323.00

371.00

141.00

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															322.00	426.00	316.00	270.00	143.00

Hikma Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Hikma Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (Hikma Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HIKl:UK HIK:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.